Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information
Newsfile Corp•12/11/2026•16:38 ET
0
Key Highlights
- ➤Q2 revenue $40.1 million, up 10.4% year over year
- ➤Operating income $9.9 million, up 21% year over year
- ➤Net income attributable to common shareholders reached $17.3 million
- ➤Amphetamine and naltrexone product revenues drove quarterly growth
- ➤Management conference call scheduled for November 13, 2026
Conference Call Scheduled for Friday, November 13, 2026 at 11:30 AM EST
Northvale, New Jersey--(Newsfile Corp. - November 12, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the Second quarter of fiscal year 2027 ended September 30, 2026 ("Second Quarter").
Get started
Create a free account to read the full story.